PERNIX THERAPEUTICS HOLDINGS, INC.
DelistedCIK 1024126fmd_0Y9GDTG1DDEJAFYYN8MCER7D6XManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2018, 35 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 61 | 61 | 85 | 122 | 176 | 141 | 146 |
| Cost of revenue | 5 | 21 | 0 | 6 | 3 | 51 | 43 | 45 |
| Net interest income | 0 | (0) | (0) | (4) | (19) | – | – | – |
| Gross profit | – | 40 | 61 | 78 | 119 | 124 | 98 | 101 |
| Realized investment gains (losses) | – | – | 0 | 4 | 0 | 0 | – | – |
| Research and development | 1 | 1 | 1 | 5 | 4 | 8 | 6 | 1 |
| Selling, general and administrative | 15 | 22 | 35 | 63 | 60 | 97 | 99 | 77 |
| Impairment of real estate | – | 0 | – | – | – | – | – | – |
| Operating income | 10 | 13 | (2) | (54) | (30) | (101) | (140) | (56) |
| Interest expense | – | – | – | – | – | – | 38 | 37 |
| Interest and investment income | – | – | – | 0 | 0 | 0 | 0 | – |
| Other non-operating income (expense) | 1 | (0) | (0) | 7 | (19) | (40) | (29) | (20) |
| Income before taxes | – | 13 | (2) | (46) | (49) | (141) | (169) | (77) |
| Income tax expense | 1 | 5 | (0) | (21) | (14) | 7 | 0 | 0 |
| Net income from continuing operations | 11 | 13 | (2) | (26) | (35) | (148) | (170) | (77) |
| Net income | 9 | 8 | (1) | (26) | (35) | (148) | (170) | (77) |